GILEAD SCIENCES, INC. 4

Johanna Mercier had 2,797 RSUs vest into Gilead common shares and 1,347 shares withheld for taxes, leaving her with 119,684 shares owned.

On September 10, 2026, Johanna Mercier, Chief Commercial & Corporate Affairs Officer of Gilead Sciences, Inc., had 2,797 restricted stock units vest and convert into common stock, increasing her direct holdings to 121,031 shares before a concurrent tax-related disposition. On the same day, 1,347 shares of common stock were withheld and disposed of at $144.81 per share (approximately $195,000 in value) to satisfy tax obligations associated with the RSU vesting, resulting in post-transaction ownership of 119,684 shares. The RSUs, each representing one share of common stock, vest over four years, with 25% vesting on the first anniversary of the grant date and the remainder vesting at 6.25% quarterly thereafter. After these transactions, she directly owns 119,684 shares of Gilead common stock, with an estimated value of about $17.3 million based on the $144.81 reference price.

Filing Facts

CIK

882095

Ticker

GILD

Form

4

Source Type

fda

Accession

0001782135-26-000031

Alert Tier

7